All Stories

  1. Aging People with Viral Infection, Novel Strategies
  2. Bone Tumor Metastasis Therapeutics, New Ideas and Perspectives
  3. COVID 19 Study, Drug Selection and Development
  4. Anticancer Drug Combinations: Different Strategies Used in the Clinic
  5. Cancer Bioinformatics, New Chapter of Personalized Medicine
  6. Pulmonary nodules, knowledge renovation and comprehensive studies
  7. Personalized Oncology: Scientific and Technical Approaches
  8. Advances in Cancer Therapeutics and Genomics for Improved Patient Outcomes
  9. Magnetic water and clinical cancer chemotherapy
  10. Nursery Services in Future
  11. Human suicide, clinical treatment overview
  12. Sexually transmitted disease diagnosis and treatments, risk factors from beyond
  13. Human suicide, risk factors and new perspective
  14. Suicide study, new approaches
  15. Human suicide, molecular framework
  16. COVID-19 knowledge and therapeutics, past, present and future
  17. Artificial intelligence for advancing nursery service
  18. Treatment improvements by pediatric Theranostics
  19. COVID-19 conception advances, epidemics, pathology and therapeutics
  20. Withdrawn: Professor Bin Xu, A Legendary Pharmacologist in People’s Republic of China
  21. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  22. Anticancer Drug Development, Pharmaceutical Progress
  23. Human Suicide, Biomedical Knowledge Advances
  24. Type 2 Diabetes Treatments in Countries of Different Economic Status
  25. Human suicide, biomedical knowledge and therapeutic advances
  26. Human Suicide, an Overview of Management Strategies
  27. COVID-19 Research, Public Health and Biomedical Basis
  28. Human Suicide, Management Landscape
  29. Anticancer Drug Development: Evaluative Architecture
  30. COVID-19 Study: A New Principle Discovery
  31. COVID-19 Study, Diagnostic and Therapeutic Transition
  32. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  33. Nursery services advances, global campaign
  34. Different approaches to bone transplantation surgery
  35. Bone Metastasis Diagnosis, Blood Biomarker Detections
  36. Anti-metastatic drug development, overview and perspectives
  37. Educational Perspectives for Nursery
  38. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  39. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  40. Suicide Curative Treatment Study and Drug Development
  41. Pulmonary nodules, is there any pathogenesis evidence?
  42. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  43. Pulmonary nodules, surgery or other medication
  44. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  45. Pulmonary Nodules, Surgery or Other Medication
  46. Anti-Metastatic Drug Developments, Utility of More Animal Models
  47. Several approaches for anticancer drug development progress
  48. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  49. COVID-19 infection for metabolic abnormal human beings
  50. Fundamental knowledge for nurses 
  51. Nursery promotion, education and system updating
  52. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  53. Covid-19 Study, Pathology and Therapeutics
  54. Acupuncture for Bone Disease Treatments, Modern Approaches
  55. Cancer Bone Metastasis, Experimental Study
  56. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  57. Osteoporosis Targeting, Possible Breakthroughs
  58. Neuropsychiatric insights for human suicide
  59. Bone Cancer and Metastasis Trials, Drug Treatment
  60. Neurobiology for human suicide
  61. Bone Disease Treatment Study, Major Pathways
  62. Pathology Study for Human Suicide
  63. Nursery activity and quality, chemistry between doctors and nurses
  64. Nursery education, narrow-range or wide-range
  65. Anticancer drug development, challenge and dilemma
  66. Life Origin on Earth, Knowledge Development
  67. HIV/AIDS treatment, therapeutic strategy break throughs
  68. Nursery education for diabetes
  69. Suicide Risks and Prevention, Neuropathogenic Study
  70. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  71. General information for nursery
  72. Historical analysis of suicide
  73. Drug sensitivity testing, a unique drug selection strategy
  74. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  75. Medical treatments for incurable diseases, palliative therapy
  76. Life Origin on Earth, Biochemical Approaches
  77. Nursery training, from technique details in schools into medical knowledge education in nursery career
  78. Herbal medicine in new era
  79. Nursery service, quality promotion
  80. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  81. RETRACTED: Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate
  82. Patient’s care and nursery in different diseases
  83. Ebola Therapeutic Study and Future Directions
  84. New HIV/AIDS Therapeutics
  85. Nursery Service in Modern Days
  86. Nursery Education, Capability and Service Promotion
  87. Nursery Science and Conventions
  88. Cancer Bioinformatics in Cancer Therapy
  89. Individualized Cancer Therapy
  90. Human Suicide Risk and Treatment Study
  91. Type 2 Diabetes Treatment and Drug Development Study
  92. Hypotheses for Life Origin on Earth, Comparison and Validation
  93. Type 2 Diabetes Study, Introduction and Perspective
  94. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  95. Anthocyanins and its biological & therapeutic characters
  96. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  97. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  98. Pathology and treatments of obesity
  99. Obesity, Risks and Managements
  100. Keep up the pace of drug development evolution and expenditure
  101. An Overview of Obesity
  102. General Topics in the Field of Personalized Cancer Therapy
  103. Human Suicide Risk Study and Treatment: A Mathematical Approach
  104. Anti-Metastatic Drug Developments: Work Out towards New Direction
  105. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  106. Drug Combination in Clinical Cancer Treatments
  107. General outlook for individualized cancer therapy
  108. Ebola origin and treatment
  109. Different Disciplines in the Field of Suicide Study
  110. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  111. HAART in HIV/AIDS Treatments
  112. Anticancer Drug Development, System Updating and Global Participations
  113. Life Origin on Earth, What is the Right Answer?
  114. Life Origin on Earth, What is the Right Answer?
  115. Anticancer Drug Development, Getting out from Bottleneck
  116. Anticancer Drug Development, Getting out from Bottleneck
  117. Human suicide study, major disciplines and treatment outcomes
  118. Anticancer drug development
  119. HIV in Human Genomes and Therapeutics
  120. HIV Biotherapy and Natural Chemotherapeutic Agents
  121. Anticancer Drug Combinations, How Far We can Go Through?
  122. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  123. Life Origin on Earth, Insights among Different Arguments
  124. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  125. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  126. Anticancer Drug Development, Breakthroughs are Waiting
  127. Cancer metastasis treatment, a key drawbacks
  128. The suicide treatment, a new model
  129. HIV Vaccine for Prevention and Cure, A Mission Possible
  130. Zika Therapy
  131. HIV vaccine
  132. Discover Natural Chemical Drugs in Modern Medicines
  133. Mathematics in biomedical science
  134. The origin of HIV
  135. Human suicide study
  136. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  137. Pharmacogenetics of Cancer Therapy
  138. Anticancer Drug Sensitivity Testing
  139. New Perspectives of HIV/AIDS Therapy Study
  140. Antidepressant treatment study
  141. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  142. Assistant cancer treatments in the clinic
  143. Drug sensitivity testing in clinical cancer treatments
  144. Anticancer drug combination in the clinic
  145. Anticancer drug pharmacogenomics in cancer chemotherapy
  146. Cost-effectiveness for personalized cancer therapy
  147. Conclusion
  148. Introduction
  149. Discussion
  150. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  151. Anti-diabetic treatments
  152. Anticancer Drug Combinational Study
  153. The Origins of HIV
  154. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  155. Anticancer Drug Combinations, A Big Momentum is Needed
  156. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  157. Future Perspectives for Controlling Ebola Epidemics
  158. Ebola Origin and Therapies
  159. Cancer Bioinformatics, its Impacts on Cancer Therapy
  160. Copyright
  161. List of figures and tables
  162. Anti-diabetic treatments, patho-therapeutic relation
  163. Origin of Ebola, hypothesis
  164. Personalized Cancer Therapy: A Perspective
  165. Rethink Of Diabetes Treatment and Drug Development
  166. Pharmacogenomics in human suicide prediction and treatments
  167. Cancer metastasis treatment study and drug developments
  168. Challenge for HIV/AIDS therapy
  169. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  170. Drug Combinations in Cancer Treatments
  171. New Insights into Individualized Antimetastatic Therapy
  172. Anticancer drugs on serum sialic acid level in mice bearing LLC
  173. Drug Combinations in Cancer Treatments
  174. Genetics in Neural Toxicity of Drugs
  175. Avian flu, pathogenesis and therapeutic study
  176. First Genetic Information Replication in Life Origin on Earth
  177. Origins of Life, A New Cooperative Model
  178. Cancer Metastases and Clinical Therapies
  179. Origins of Life, RNA world or alternative RNA world
  180. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  181. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  182. Antimetastatic Therapies according to Metastatic Cascade
  183. Genetics in antidepressant-induced suicide
  184. Pathology of Drug-induced mania & suicide
  185. Influenza treatment
  186. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  187. Individualized cancer chemotherapy
  188. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  189. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  190. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  191. Genomic study of antidepressant-induced suicide
  192. Aberrant sialylation in tumor cells
  193. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  194. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  195. Neural toxicity of drugs
  196. Anticancer activity and mechanisms of Bisdioxopiperazines
  197. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  198. 14C-probimane in the mice bearing LLC
  199. Unsatisfactory design of human AIDS genome research
  200. Antidepressant in Cancer Treatment
  201. AIDS and human genome studies, from a hypothesis to systematic approaches
  202. Antidepressants in Human suicide
  203. Mathematical model in therapeutic risk prediction
  204. Fibrinogen in neoplasm metastasis
  205. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  206. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  207. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  208. Individualized cancer chemotheray
  209. Anti-proliferative and chromosome segregation by probimane and MST-16
  210. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  211. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  212. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  213. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  214. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  215. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  216. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  217. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  218. Journal of Clinical and Medical Reviews